| A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach P Wang, J Sidney, C Dow, B Mothé, A Sette, B Peters PLoS computational biology 4 (4), e1000048, 2008 | 965 | 2008 |
| Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies YZ Jiang, D Ma, C Suo, J Shi, M Xue, X Hu, Y Xiao, KD Yu, YR Liu, Y Yu, ... Cancer cell 35 (3), 428-440. e5, 2019 | 823 | 2019 |
| Peptide binding predictions for HLA DR, DP and DQ molecules P Wang, J Sidney, Y Kim, A Sette, O Lund, M Nielsen, B Peters BMC bioinformatics 11, 1-12, 2010 | 730 | 2010 |
| Immune epitope database analysis resource Y Kim, J Ponomarenko, Z Zhu, D Tamang, P Wang, J Greenbaum, ... Nucleic acids research 40 (W1), W525-W530, 2012 | 555 | 2012 |
| Immune epitope database analysis resource (IEDB-AR) Q Zhang, P Wang, Y Kim, P Haste-Andersen, J Beaver, PE Bourne, ... Nucleic acids research 36 (suppl_2), W513-W518, 2008 | 430 | 2008 |
| Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II–restricted cytotoxic T lymphocytes D Mucida, MM Husain, S Muroi, F Van Wijk, R Shinnakasu, Y Naoe, ... Nature immunology 14 (3), 281-289, 2013 | 412 | 2013 |
| Multi-omics profiling reveals distinct microenvironment characterization and suggests immune escape mechanisms of triple-negative breast cancer Y Xiao, D Ma, S Zhao, C Suo, J Shi, MZ Xue, M Ruan, H Wang, J Zhao, ... Clinical cancer research 25 (16), 5002-5014, 2019 | 310 | 2019 |
| Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response R Arens, P Wang, J Sidney, A Loewendorf, A Sette, SP Schoenberger, ... The Journal of Immunology 180 (10), 6472-6476, 2008 | 141 | 2008 |
| Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition H Chang, Y Liu, M Xue, H Liu, S Du, L Zhang, P Wang Nucleic acids research 44 (6), 2514-2527, 2016 | 134 | 2016 |
| Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT Y Liu, M Xue, S Du, W Feng, K Zhang, L Zhang, H Liu, G Jia, L Wu, X Hu, ... Nature communications 10 (1), 1637, 2019 | 110 | 2019 |
| Structural genomics analysis of alternative splicing and application to isoform structure modeling P Wang, B Yan, J Guo, C Hicks, Y Xu Proceedings of the National Academy of Sciences 102 (52), 18920-18925, 2005 | 90 | 2005 |
| PHF5A epigenetically inhibits apoptosis to promote breast cancer progression YZ Zheng, MZ Xue, HJ Shen, XG Li, D Ma, Y Gong, YR Liu, F Qiao, ... Cancer Research 78 (12), 3190-3206, 2018 | 77 | 2018 |
| Quantitative evaluation of protein–DNA interactions using an optimized knowledge-based potential Z Liu, F Mao, J Guo, B Yan, P Wang, Y Qu, Y Xu Nucleic acids research 33 (2), 546-558, 2005 | 77 | 2005 |
| 3′ UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network L Li, D Wang, M Xue, X Mi, Y Liang, P Wang Scientific reports 4 (1), 5406, 2014 | 66 | 2014 |
| Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing GT Lang, YZ Jiang, JX Shi, F Yang, XG Li, YC Pei, CH Zhang, D Ma, ... Nature Communications 11 (1), 5679, 2020 | 64 | 2020 |
| Automating document classification for the Immune Epitope Database P Wang, AA Morgan, Q Zhang, A Sette, B Peters BMC bioinformatics 8, 1-10, 2007 | 61 | 2007 |
| Limitations of Ab initio predictions of peptide binding to MHC class II molecules H Zhang, P Wang, N Papangelopoulos, Y Xu, A Sette, PE Bourne, O Lund, ... PloS one 5 (2), e9272, 2010 | 52 | 2010 |
| Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses C Chen, C Dow, P Wang, J Sidney, A Read, A Harmsen, JE Samuel, ... PLoS One 6 (3), e17712, 2011 | 50 | 2011 |
| Identification of spatially variable genes with graph cuts K Zhang, W Feng, P Wang Nature Communications 13 (1), 5488, 2022 | 44 | 2022 |
| Hepatobiliary tumor organoids reveal HLA class I neoantigen landscape and antitumoral activity of neoantigen peptide enhanced with immune checkpoint inhibitors W Wang, T Yuan, L Ma, Y Zhu, J Bao, X Zhao, Y Zhao, Y Zong, Y Zhang, ... Advanced science 9 (22), 2105810, 2022 | 38 | 2022 |
Bjoern PetersProfessor at La Jolla Institute for ImmunologyVerified email at lji.org
